熊去氧胆酸联合低分子肝素钙注射液与丁二磺酸腺苷蛋氨酸治疗妊娠期肝内胆汁淤积症的临床研究

目的:观察熊去氧胆酸联合低分子肝素钙注射液与丁二磺酸腺苷蛋氨酸治疗妊娠期肝内胆汁淤积症(intrahepatic cholestasis of pregnancy,ICP)患者的临床疗效,分析患者血清胆汁酸(TBA)、谷丙转氨酶(ALT)和谷草转氨酶(AST)水平的变化及妊娠情况。方法:将收治的135例ICP患者按照治疗方法不同分为A、B、C组,各45例,3组均行常规检查。A组口服熊去氧胆酸片;B组口服熊去氧胆酸片基础上注射丁二磺酸腺苷蛋氨酸治疗;C组在B组治疗基础上联合低分子肝素钙治疗。对比3组临床疗效和妊娠情况,检测所有受试者治疗前后外周血TBA、ALT和AST水平。结果:治疗后,C组临床...

Full description

Saved in:
Bibliographic Details
Published in国际妇产科学杂志 Vol. 44; no. 6; pp. 642 - 646
Main Author 陈志敏;牛阳;刘肖;赵双一
Format Journal Article
LanguageChinese
Published 450052,郑州大学第一附属医院产科 2017
Subjects
Online AccessGet full text

Cover

Loading…
Abstract 目的:观察熊去氧胆酸联合低分子肝素钙注射液与丁二磺酸腺苷蛋氨酸治疗妊娠期肝内胆汁淤积症(intrahepatic cholestasis of pregnancy,ICP)患者的临床疗效,分析患者血清胆汁酸(TBA)、谷丙转氨酶(ALT)和谷草转氨酶(AST)水平的变化及妊娠情况。方法:将收治的135例ICP患者按照治疗方法不同分为A、B、C组,各45例,3组均行常规检查。A组口服熊去氧胆酸片;B组口服熊去氧胆酸片基础上注射丁二磺酸腺苷蛋氨酸治疗;C组在B组治疗基础上联合低分子肝素钙治疗。对比3组临床疗效和妊娠情况,检测所有受试者治疗前后外周血TBA、ALT和AST水平。结果:治疗后,C组临床有效率(93.33%)高于A、B组(P〈0.05)。治疗前,3组患者瘙痒评分比较差异无统计学意义(P〉0.05);治疗后,3组瘙痒评分较组内治疗前均降低(P〈0.05),且治疗后C组低于A和B组(P〈0.05),B组低于A组(P〈0.05)。治疗前,3组TBA、ALT和AST水平差异无统计学意义(P〉0.05);治疗后,3组TBA、ALT和AST水平较组内治疗前均降低(P〈0.05),且治疗后C组低于A和B组,B组低于A组(P〈0.05)。治疗后,C组患者剖宫产、早产、胎儿窘迫和羊水污染发生率均低于A组和B组,且总不良反应发生率明显低于A组和B组(P〈0.05)。结论:熊去氧胆酸联合低分子肝素钙注射液与丁二磺酸腺苷蛋氨酸治疗ICP患者的临床疗效显著,能更有效缓解患者的瘙痒程度,降低血清TBA、ALT和AST水平,保护肝脏,减少胎儿窘迫和羊水污染等情况的发生,具有较高临床价值,可作为ICP的治疗方案进一步推广应用。
AbstractList 目的:观察熊去氧胆酸联合低分子肝素钙注射液与丁二磺酸腺苷蛋氨酸治疗妊娠期肝内胆汁淤积症(intrahepatic cholestasis of pregnancy,ICP)患者的临床疗效,分析患者血清胆汁酸(TBA)、谷丙转氨酶(ALT)和谷草转氨酶(AST)水平的变化及妊娠情况。方法:将收治的135例ICP患者按照治疗方法不同分为A、B、C组,各45例,3组均行常规检查。A组口服熊去氧胆酸片;B组口服熊去氧胆酸片基础上注射丁二磺酸腺苷蛋氨酸治疗;C组在B组治疗基础上联合低分子肝素钙治疗。对比3组临床疗效和妊娠情况,检测所有受试者治疗前后外周血TBA、ALT和AST水平。结果:治疗后,C组临床有效率(93.33%)高于A、B组(P〈0.05)。治疗前,3组患者瘙痒评分比较差异无统计学意义(P〉0.05);治疗后,3组瘙痒评分较组内治疗前均降低(P〈0.05),且治疗后C组低于A和B组(P〈0.05),B组低于A组(P〈0.05)。治疗前,3组TBA、ALT和AST水平差异无统计学意义(P〉0.05);治疗后,3组TBA、ALT和AST水平较组内治疗前均降低(P〈0.05),且治疗后C组低于A和B组,B组低于A组(P〈0.05)。治疗后,C组患者剖宫产、早产、胎儿窘迫和羊水污染发生率均低于A组和B组,且总不良反应发生率明显低于A组和B组(P〈0.05)。结论:熊去氧胆酸联合低分子肝素钙注射液与丁二磺酸腺苷蛋氨酸治疗ICP患者的临床疗效显著,能更有效缓解患者的瘙痒程度,降低血清TBA、ALT和AST水平,保护肝脏,减少胎儿窘迫和羊水污染等情况的发生,具有较高临床价值,可作为ICP的治疗方案进一步推广应用。
目的:观察熊去氧胆酸联合低分子肝素钙注射液与丁二磺酸腺苷蛋氨酸治疗妊娠期肝内胆汁淤积症(intrahepatic cholestasis of pregnancy,ICP)患者的临床疗效,分析患者血清胆汁酸(TBA)、谷丙转氨酶(ALT)和谷草转氨酶(AST)水平的变化及妊娠情况.方法:将收治的135例ICP患者按照治疗方法不同分为A、B、C组,各45例,3组均行常规检查.A组口服熊去氧胆酸片;B组口服熊去氧胆酸片基础上注射丁二磺酸腺苷蛋氨酸治疗;C组在B组治疗基础上联合低分子肝素钙治疗.对比3组临床疗效和妊娠情况,检测所有受试者治疗前后外周血TBA、ALT和AST水平.结果:治疗后,C组临床有效率(93.33%)高于A、B组(P<0.05).治疗前,3组患者瘙痒评分比较差异无统计学意义(P>0.05);治疗后,3组瘙痒评分较组内治疗前均降低(P<0.05),且治疗后C组低于A和B组(P<0.05),B组低于A组(P<0.05).治疗前,3组TBA、ALT和AST水平差异无统计学意义(P>0.05);治疗后,3组TBA、ALT和AST水平较组内治疗前均降低(P<0.05),且治疗后C组低于A和B组,B组低于A组(P<0.05).治疗后,C组患者剖宫产、早产、胎儿窘迫和羊水污染发生率均低于A组和B组,且总不良反应发生率明显低于A组和B组(P<0.05).结论:熊去氧胆酸联合低分子肝素钙注射液与丁二磺酸腺苷蛋氨酸治疗ICP患者的临床疗效显著,能更有效缓解患者的瘙痒程度,降低血清TBA、ALT和AST水平,保护肝脏,减少胎儿窘迫和羊水污染等情况的发生,具有较高临床价值,可作为ICP的治疗方案进一步推广应用.
Abstract_FL Objective:To observe the clinical efficacy of ursodeoxycholic acid combined with low molecular weight heparin calcium injection and adenosine methionine methionine in the treatment of intrahepatic cholestasis of pregnancy. The levels of serum bile acid (TBA), alanine aminotransferase (ALT) and aspartate aminotransferase (AST) were analyzed. Methods:According to different treatment methods, 135 patients with ICP were divided into A, B and C group (n=45). The three groups were treated by routine therapy. Group A patients with oral ursodeoxycholic acid tablets. On this basis, group B was injected with adenosylmethionine disulfonate. On group B basis, group C was injected with low molecular weight heparin calcium injection. The clinical efficacy and pregnancy status of the three groups were compared and the levels of TBA, ALT and AST were measured in all subjects before and after treatment. Results:After treatment, the clinical effective rate of group C was 93.33%higher than that of group A and B (P<0.05). Before treatment, there was no significant difference in the score of itching between the three groups (P>0.05). After treatment, the scores of the three groups were significantly lower than those before treatment (P<0.05), and group C was lower than group A and B (P<0.05), and group B was lower than group A (P<0.05). Before treatment, there was no significant difference in the levels of TBA, ALT and AST between the three groups ( P>0.05). After treatment, the levels of TBA, ALT and AST in the three groups were significantly lower than those before treatment ( P<0.05), and group C was lower than group A and B (P<0.05), and group B was lower than group A (P<0.05). After treatment, the incidence of cesarean section, premature birth, fetal distress and amniotic fluid pollution in group C were lower than those in group A and B, and the overall incidence of group C was significantly lower than that of group A and B ( P<0.05). Conclusions:Ursodeoxycholic acid combined with low molecular weight heparin calcium injection and adenosine methionine methionine in the treatment of ICP patients with clinical efficacy is significant. And it can be more effective inrelieving the degree of pruritus, reducing serum TBA, ALT and AST levels, protecting the liver, reducing fetal distress and amniotic fluid Pollution and othercircumstances, which is the clinical potential of the ideal program.
Author 陈志敏;牛阳;刘肖;赵双一
AuthorAffiliation 郑州大学第一附属医院产科,450052
AuthorAffiliation_xml – name: 450052,郑州大学第一附属医院产科
Author_FL ZHAO Shuang-yi
CHEN Zhi-min
NIU Yang
LIU Xiao
Author_FL_xml – sequence: 1
  fullname: CHEN Zhi-min
– sequence: 2
  fullname: NIU Yang
– sequence: 3
  fullname: LIU Xiao
– sequence: 4
  fullname: ZHAO Shuang-yi
Author_xml – sequence: 1
  fullname: 陈志敏;牛阳;刘肖;赵双一
BookMark eNotkN1LwlAAxfdgkJn_RI_B4G53u9seQ_oCoRffx3bbzD5mKaE-rnSJhkhI0hcJRdpDZCY6Jv03u7vzv2hhT4cDv3MOnBUmZuUtI8bEOSQJLCdLYJlJFos5HQAeQAUJQpyxqdMgrVkw7IeXzrzmhnaHtOv-T4vUHfLRDi-e6Lg3v7kLvgdkWA0mI99t-a7te9f0xfvja17YnIYPzWA4iGwwmtHbLnlrkEEveHyO4sSpRc3Blx1MX2n_k3av6H3Vd8fEa9Beh75PVpklUzsuGsl_TTCZrc1MaodN723vpjbSLEY8YCWEZRNhAcsYYKjw0NA5KPKShmSDBwYQFHlfA4qiA1GXRYQ53gCiaAIJQl03TQUmmPVFbUmzTM3Kqof584IVDarZUqWsmviozANOAghwIILXFjA-yFvZs1yEnxZyJ1qhokZXchBySIa_lwWYCA
ContentType Journal Article
Copyright Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
Copyright_xml – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
DBID 2RA
92L
CQIGP
W91
~WA
2B.
4A8
92I
93N
PSX
TCJ
DatabaseName 维普_期刊
中文科技期刊数据库-CALIS站点
中文科技期刊数据库-7.0平台
中文科技期刊数据库-医药卫生
中文科技期刊数据库- 镜像站点
Wanfang Data Journals - Hong Kong
WANFANG Data Centre
Wanfang Data Journals
万方数据期刊 - 香港版
China Online Journals (COJ)
China Online Journals (COJ)
DatabaseTitleList

DeliveryMethod fulltext_linktorsrc
DocumentTitle_FL Clinical Study of Ursodeoxycholic Acid Combined with Low Molecular Weight Heparin Calcium Injection and Ademetionine 1,4-Butanedisulfonate in the Treatment of Intrahepatic Cholestasis of Pregnancy
EndPage 646
ExternalDocumentID gwyx_fckx201706010
674133168
GroupedDBID 2RA
92L
ALMA_UNASSIGNED_HOLDINGS
CDYEO
CQIGP
W91
~WA
2B.
4A8
92I
93N
PSX
TCJ
ID FETCH-LOGICAL-c620-76c8f6c4c8c0c3923eb13527a68e20e0498da099b05b856c12e055f0733bbff93
ISSN 1674-1870
IngestDate Thu May 29 04:07:05 EDT 2025
Wed Feb 14 10:03:37 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords Tauro-ursodesoxycholic acid
Heparin,low-molecular-weight
牛磺熊去氧胆酸
Pregnancy complications
胎儿窘迫
Cholestasis,intrahepatic
肝素,低分子量
S-adenosylmethionine
胆汗淤积,肝内
S-腺苷甲硫氨酸
Intrahepatic cholestasis of pregnancy
Fetal distress
妊娠期肝内胆汁淤积症
妊娠期并发症
Language Chinese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c620-76c8f6c4c8c0c3923eb13527a68e20e0498da099b05b856c12e055f0733bbff93
Notes 12-1399/R
PageCount 5
ParticipantIDs wanfang_journals_gwyx_fckx201706010
chongqing_primary_674133168
PublicationCentury 2000
PublicationDate 2017
PublicationDateYYYYMMDD 2017-01-01
PublicationDate_xml – year: 2017
  text: 2017
PublicationDecade 2010
PublicationTitle 国际妇产科学杂志
PublicationTitleAlternate Foreign Medical Sciences(Obstet Gynecol Fascicle)
PublicationTitle_FL Journal Of International Obstetrics And Gynecology
PublicationYear 2017
Publisher 450052,郑州大学第一附属医院产科
Publisher_xml – name: 450052,郑州大学第一附属医院产科
SSID ssib002039644
ssib008858041
ssib005319428
ssib051371002
ssib025873268
ssib008679380
ssib002039729
ssib010102505
ssib017477451
ssib036437542
Score 2.0620914
Snippet 目的:观察熊去氧胆酸联合低分子肝素钙注射液与丁二磺酸腺苷蛋氨酸治疗妊娠期肝内胆汁淤积症(intrahepatic cholestasis of...
目的:观察熊去氧胆酸联合低分子肝素钙注射液与丁二磺酸腺苷蛋氨酸治疗妊娠期肝内胆汁淤积症(intrahepatic cholestasis of...
SourceID wanfang
chongqing
SourceType Aggregation Database
Publisher
StartPage 642
SubjectTerms 低分子量;S-腺苷甲硫氨酸;胎儿窘迫;妊娠期肝内胆汁淤积症
肝内;妊娠期并发症;牛磺熊去氧胆酸;肝素
胆汗淤积
Title 熊去氧胆酸联合低分子肝素钙注射液与丁二磺酸腺苷蛋氨酸治疗妊娠期肝内胆汁淤积症的临床研究
URI http://lib.cqvip.com/qk/94965A/201706/674133168.html
https://d.wanfangdata.com.cn/periodical/gwyx-fckx201706010
Volume 44
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR1da9RAMNT64osoKtaqFHQfT_K1m93HpJejCPpUoW_HXXppQbj6UbH27bQ9SyulSLH4hQXF1gex1tIeLf6bS3L9F85MctcoIiqEsDuZnZ2PJDuTzc5q2lWrGoKTjLsGjPNKwTbMSkFZqlZQFUcJM7RkQDP4N26KkVv29TE-1ndsLvfX0oPp6rVg9rfrSv7HqgADu-Iq2X-wbI8oAKAM9oUzWBjOf2Vj5jtMCiZd5nMmfeZ5zBfM05nrMF8yaeFVXzHJmScJYjBlI7LSmQSIzbwiNsTmkpA5c4t4FZFNporYhWczV0c6CiCKurCYKxEZ-pI2QeAwiaAkgmnBoILL5DDScS0s_8QPJwgUPOYRz8rDciaFzCETfRTQYUow5RCrXdkBEzkE-DBTpRzznPTDc9oAOgYxJrBH1ybG4CgRZdCnQwWX5CIpPNIYSuESsk46hIICqfPOPSnWQ5WirojzjEkn04PrZN0pI1O1SywBq8Aw9lJiqucZdMnI3hXCBZlKzCJNSIUdIppEmyCQLKlkVweCgHCV4-FTW7RGah89_9EnXd2ajVDCsQuGTHdb6Q5haQrN7FHNj0ciTV2WuTbC_iXrOPkxQNCwcP8yTAEBI2S_dtz1il7pyIvTLSXyXiDU85O9-BrPR7GYw9HKDQtScsxy1a0bmMaQHw0zEBNDDHI0OW1y6UBQ0aNn4dxyd59mqMObBVNS0X8MXWVgZpTJqfrEXfD3aPldPazUJ3Ke4ugp7WQW4g256fN6WuubnTyjNZLmYrR8EG9tdJ40D-dbncZqtLLQ_r4cLTSjzyudx2-TnfXD5y_jb5vR1ly8u91uLbdbjfb-s-T9PuLP73eW9jqvl-KtTajG2wfJi7Xo42K0uR6_eQfNo-Y8UI6_NuK9D8nGl2TtafJqrt3aifYXk_XV5NPuWW205I8OjxSy7U8KgTD1giMCGYrADmSgBxDFWOBVQbTkVISsmXoNIns5XoH4DhRSlVwEhlnTOQ9xE9ZqNQyVdU7rr0_Va-e1ocAJQjsQll0JbVtxUzqBFBAXyeq4XQuVPqAN9rRXvpNmuSn3bosB7Uqmz3L27rtfnnj4aKYcBrdnzDT_lqFf-CONQe0EYqbfLi9q_dP3HtQugTc_Xb2c3W0_AKmGzLM
linkProvider EBSCOhost
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E7%86%8A%E5%8E%BB%E6%B0%A7%E8%83%86%E9%85%B8%E8%81%94%E5%90%88%E4%BD%8E%E5%88%86%E5%AD%90%E8%82%9D%E7%B4%A0%E9%92%99%E6%B3%A8%E5%B0%84%E6%B6%B2%E4%B8%8E%E4%B8%81%E4%BA%8C%E7%A3%BA%E9%85%B8%E8%85%BA%E8%8B%B7%E8%9B%8B%E6%B0%A8%E9%85%B8%E6%B2%BB%E7%96%97%E5%A6%8A%E5%A8%A0%E6%9C%9F%E8%82%9D%E5%86%85%E8%83%86%E6%B1%81%E6%B7%A4%E7%A7%AF%E7%97%87%E7%9A%84%E4%B8%B4%E5%BA%8A%E7%A0%94%E7%A9%B6&rft.jtitle=%E5%9B%BD%E9%99%85%E5%A6%87%E4%BA%A7%E7%A7%91%E5%AD%A6%E6%9D%82%E5%BF%97&rft.au=%E9%99%88%E5%BF%97%E6%95%8F%3B%E7%89%9B%E9%98%B3%3B%E5%88%98%E8%82%96%3B%E8%B5%B5%E5%8F%8C%E4%B8%80&rft.date=2017&rft.issn=1674-1870&rft.volume=44&rft.issue=6&rft.spage=642&rft.epage=646&rft.externalDocID=674133168
thumbnail_s http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F94965A%2F94965A.jpg
http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Fgwyx-fckx%2Fgwyx-fckx.jpg